Wang Yan, Kim Bokyung, Gong Shuaishuai, Park Joohyun, Zhu Meina, Wong Evelyn M, Park Audrey Y, Chernoff Jonathan, Guo Fuzheng
Department of Neurology, UC Davis School of Medicine; Institute for Pediatric Regenerative Medicine (IPRM), Shriners Hospitals for Children, Sacramento, CA 95817.
Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111.
bioRxiv. 2024 Apr 29:2024.04.26.591153. doi: 10.1101/2024.04.26.591153.
Appropriate proliferation and repopulation of oligodendrocyte progenitor cells (OPCs) determine successful (re)myelination in homeostatic and demyelinating brains. Activating mutations in p21-activated kinase 1 (PAK1) cause intellectual disability, neurodevelopmental abnormality, and white matter anomaly in children. It remains unclear if and how PAK1 regulates oligodendroglial development. Here, we report that PAK1 controls proliferation and regeneration of OPCs. Unlike differentiating oligodendrocytes, OPCs display high PAK1 activity which maintains them in a proliferative state by modulating PDGFRa-mediated mitogenic signaling. PAK1-deficient or kinase-inhibited OPCs reduce their proliferation capacity and population expansion. Mice carrying OPC-specific PAK1 deletion or kinase inhibition are populated with fewer OPCs in the homeostatic and demyelinated CNS than control mice. Together, our findings suggest that kinase-activating PAK1 mutations stall OPCs in a progenitor state, impacting timely oligodendroglial differentiation in the CNS of affected children and that PAK1 is a potential molecular target for replenishing OPCs in demyelinating lesions.
少突胶质前体细胞(OPCs)的适度增殖和再填充决定了稳态和脱髓鞘脑内成功的(再)髓鞘形成。p21激活激酶1(PAK1)的激活突变会导致儿童智力残疾、神经发育异常和白质异常。PAK1是否以及如何调节少突胶质细胞发育仍不清楚。在此,我们报告PAK1控制OPCs的增殖和再生。与正在分化的少突胶质细胞不同,OPCs表现出高PAK1活性,通过调节血小板衍生生长因子受体α(PDGFRα)介导的促有丝分裂信号,使其维持在增殖状态。PAK1缺陷或激酶抑制的OPCs降低了它们的增殖能力和群体扩张。与对照小鼠相比,携带OPC特异性PAK1缺失或激酶抑制的小鼠在稳态和脱髓鞘的中枢神经系统中OPCs数量更少。总之,我们的研究结果表明,激酶激活的PAK1突变使OPCs停滞在祖细胞状态,影响受影响儿童中枢神经系统中少突胶质细胞的及时分化,并且PAK1是在脱髓鞘病变中补充OPCs的潜在分子靶点。